Literature DB >> 22955499

The immune response induced by DNA vaccine expressing nfa1 gene against Naegleria fowleri.

Jong-Hyun Kim1, Sang-Hee Lee, Hae-Jin Sohn, Jinyoung Lee, Yong-Joon Chwae, Sun Park, Kyongmin Kim, Ho-Joon Shin.   

Abstract

The pathogenic free-living amoeba, Naegleria fowleri, causes fatal primary amoebic meningoencephalitis in experimental animals and in humans. The nfa1 gene that was cloned from N. fowleri is located on pseudopodia, especially amoebic food cups and plays an important role in the pathogenesis of N. fowleri. In this study, we constructed and characterized retroviral vector and lentiviral vector systems for nfa1 DNA vaccination in mice. We constructed the retroviral vector (pQCXIN) and the lentiviral vector (pCDH) cloned with the egfp-nfa1 gene. The expression of nfa1 gene in Chinese hamster ovary cell and human primary nasal epithelial cell transfected with the pQCXIN/egfp-nfa1 vector or pCDH/egfp-nfa1 vector was observed by fluorescent microscopy and Western blotting analysis. Our viral vector systems effectively delivered the nfa1 gene to the target cells and expressed the Nfa1 protein within the target cells. To evaluate immune responses of nfa1-vaccinated mice, BALB/c mice were intranasally vaccinated with viral particles of each retro- or lentiviral vector expressing nfa1 gene. DNA vaccination using viral vectors expressing nfa1 significantly stimulated the production of Nfa1-specific IgG subclass, as well as IgG levels. In particular, both levels of IgG2a (Th1) and IgG1 (Th2) were significantly increased in mice vaccinated with viral vectors. These results show the nfa1-vaccination induce efficiently Th1 type, as well as Th2 type immune responses. This is the first report to construct viral vector systems and to evaluate immune responses as DNA vaccination in N. fowleri infection. Furthermore, these results suggest that nfal vaccination may be an effective method for treatment of N. fowleri infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955499     DOI: 10.1007/s00436-012-3093-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  37 in total

Review 1.  Primary amoebic meningo-encephalitis. An appraisal of present knowledge.

Authors:  R F Carter
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

2.  Pathogenic Naegleria and Hartmannella (Acenthamoeba).

Authors:  C G Culbertson
Journal:  Ann N Y Acad Sci       Date:  1970-10-30       Impact factor: 5.691

Review 3.  Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis.

Authors:  A S Mustafa
Journal:  Curr Pharm Biotechnol       Date:  2001-06       Impact factor: 2.837

4.  Effects of immunization with the rNfa1 protein on experimental Naegleria fowleri-PAM mice.

Authors:  Y J Lee; J H Kim; H J Sohn; J Lee; S Y Jung; Y J Chwae; K Kim; S Park; H J Shin
Journal:  Parasite Immunol       Date:  2011-07       Impact factor: 2.280

5.  Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.

Authors:  Alberto Yairh Limon-Flores; Rodrigo Cervera-Cetina; Juan L Tzec-Arjona; Lorena Ek-Macias; Gilma Sánchez-Burgos; Maria J Ramirez-Sierra; J Vladimir Cruz-Chan; Nicole R VanWynsberghe; Eric Dumonteil
Journal:  Vaccine       Date:  2010-09-16       Impact factor: 3.641

6.  Immunoblot analysis of IgA antibodies to Naegleria fowleri in human saliva and serum.

Authors:  V Rivera-Aguilar; D Hernández-Martínez; S Rojas-Hernández; G Oliver-Aguillón; V Tsutsumi; N Herrera-González; R Campos-Rodríguez
Journal:  Parasitol Res       Date:  2000-09       Impact factor: 2.289

Review 7.  Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.

Authors:  Donatella Rm Negri; Zuleika Michelini; Roberta Bona; Maria Blasi; Piero Filati; Pasqualina Leone; Alessandra Rossi; Marina Franco; Andrea Cara
Journal:  Expert Opin Biol Ther       Date:  2011-03-25       Impact factor: 4.388

8.  Primary amoebic meningoencephalitis in Britain.

Authors:  J Apley; S K Clarke; A P Roome; S A Sandry; G Saygi; B Silk; D C Warhurst
Journal:  Br Med J       Date:  1970-03-07

9.  Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies.

Authors:  A R Stevens; S T Shulman; T A Lansen; M J Cichon; E Willaert
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

10.  Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity.

Authors:  L Haan; W R Verweij; M Holtrop; R Brands; G J van Scharrenburg; A M Palache; E Agsteribbe; J Wilschut
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

View more
  2 in total

1.  Vaccination with lentiviral vector expressing the nfa1 gene confers a protective immune response to mice infected with Naegleria fowleri.

Authors:  Jong-Hyun Kim; Hae-Jin Sohn; Jinyoung Lee; Hee-Jong Yang; Yong-Joon Chwae; Kyongmin Kim; Sun Park; Ho-Joon Shin
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

2.  Genome-wide identification of pathogenicity factors of the free-living amoeba Naegleria fowleri.

Authors:  Denise C Zysset-Burri; Norbert Müller; Christian Beuret; Manfred Heller; Nadia Schürch; Bruno Gottstein; Matthias Wittwer
Journal:  BMC Genomics       Date:  2014-06-19       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.